BioSpace News Archive

YPrime, LLC., a global leader in cloud-based eClinical solutions, announced today the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform

First COVID-19 testing event launched by a partnership among Quest Diagnostics, Choose Healthy Life and United Way of New York City at Harlem’s historic Abyssinian Baptist Church

Catalyst Biosciences, Inc., announced that it is offering shares of its common stock in an underwritten public offering.

– 37 Percent of Patients Treated with Mitapivat Achieved ≥33% Reduction in Transfusion Burden Compared to Individual Historical Transfusion Burden Standardized to 24 Weeks (1-Sided p=0.0002) – – 22 Percent of Patients Treated with Mitapivat Were Transfusion-Free During the 24-Week Fixed Dose Period – – Safety Profile Consistent with Previously Reported Data

Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously announced underwritten public offering of common stock. Precigen sold 17,250,000 shares of its common stock at a public offering price of $7.50 per share, including the exercise in full by the underwriters

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will announce its fourth-quarter and full-year 2020 financial results before the market opens on Wednesday, February 10, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date.

T2 Biosystems, Inc. (NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and full year 2020. Financial and Operational Highlights Preliminary unaudited fourth quarter 2020 total revenue is expected to be $7.8 million, including product revenue of $5.8 million, representing growth of 155% and 274% respectively, com

The new year is a great time to evaluate your overall health, but while routine physical exams, eye exams and dental appointments have become commonplace, one area of our health is still oftentimes overlooked: our hearing health.

Brewer Is a 35-Year Consumer and Retail Industry Veteran with Deep Experience in Transformational, Operational and Digital Strategies

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates.